(A–F), Absence of superoxide flashes in 143B cells completely devoid of mitochondrial DNA (ρ° 143B). Superoxide flashes exhibiting a reduction in TMRM fluorescence were readily observed in wild type 143B TK− human osteosarcoma cells (WT 143B) as shown by fluorescence traces (A) and three representative diaries of superoxide flash incidence (each vertical tick denotes a flash event, C), but not in ρ° 143B cells (B and D) in spite of the presence of ΔΨm fluctuations (B). Atractyloside (Atra, 20 µM) did not rescue superoxide flash activity in ρ° 143B cells (E). Scale bars in (B) also apply to (A). (F) Statistics of superoxide flash frequency in WT and ρ° 143B cells. Data are mean ± SEM. n = 5–21 cells. (G) Attenuated superoxide flash activity in ETC-deficient cells. Upper panel: Inhibition of mitochondrial DNA replication by treatment of PC12 cells with ethidium bromide (EB, 200 ng/ml) for up to 60 days (referred to as ρ− PC12 cells) resulted in a time-dependent decrease in the expression of the mitochondrial DNA-encoded cytochrome C oxidase subunit I (COX-1). Lower panel: a significant decrease in the frequency of superoxide flashes was observed in ρ− PC12 cells. R&A: rotenone (5 µM) and antimycin A (5 µg/ml). Data are mean ± SEM. n = 16–46 cells. *, P<0.05 versus wild type (WT PC12) cells. #, P<0.01 versus –R&A. (H) Inhibition of superoxide flash activity in rat adult cardiac myocytes by rotenone (Rot, 5 µM), antimycin A (AA, 5 µg/ml), myxothiazol (Myx, 5 µM), sodium cyanide (CN, 5 mM), oligomycin (5 µM), and FCCP (300 nM). Data are mean ± SEM. n = 7–18 cells. †, P<0.001 versus control. Label of Y axis in (F) applies to (F)–(H).